- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Vilin Bio Med Limited — Updates, 14-07-2026: General Updates
14-07-2026 | 06:32 pm
14-07-2026 | 06:32 pm
Vilin Bio Med is incorporating two wholly-owned subsidiaries: Vilo Speciality Pharma to focus on Oncology products, and Axia Pharma for general & generic pharmaceuticals. Each new entity has a proposed authorized capital of 0.1 Cr, signaling strategic expansion in the pharma sector.
No comments yet. Be the first to comment!